The significant associations between HMGB1 deficiency and dismal tumor phenotype in ccRCC, urothelial carcinoma, and invasive breast carcinomas of no special type (NST) argue for low HMGB1 expression levels, going along with aggressive cancer behavior at least in certain cancer entities. This evidence concerns the gene HMGB1 and cancer.